Company profilePharmaceutical#701 of 1,318 in Pakistan✓ No DRAP alerts

Health care pharmaceuticals DML: 000905

Pharmaceutical company · 14 brands · 35 molecules

14 registered products 12 pharmaceutical brands 35 distinct molecules 0 DRAP alerts

Company overview

14
registered products
12
pharmaceutical brands
35
distinct molecules
0
therapeutic classes
0
DRAP alerts

Health care pharmaceuticals DML: 000905 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 14 product registrations across 35 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Health

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20251

Top molecules by brand count

Ibuprofen ...... 100 Mg1 brand
Ibuprofen1 brand
Miconazole Nitrate ...... 20 Mg1 brand
Miconazole ...... 20 Mg1 brand
Fluconazole ...... 150 Mg1 brand
Fluconazole ...... 50 Mg1 brand
Azithromycin ...... 500 Mg1 brand
Azithromycin ...... 200 Mg1 brand
Azithromycin....................250Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official19 products · Rs 72.79 – Rs 732.02
Median across source: Rs 276.27

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Atco Pharma International (Pvt) Ltd holds 230 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline
MEDIATE PHARMACEUTICALS (PVT) LTD holds 112 molecules not in this portfolio
AcyclovirAlendronateAmlodipineAmoxicillinAmpicillinAmpicillin Base
Global Pharmaceuticals Pakistan holds 144 molecules not in this portfolio
AmikacinAmlodipineAmocycillinAmoxicillinAmoxicillin AmoxicillintrihydrateAmoxycillin

Get the full profile for Health

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.